Measuring vaccination willingness in response to COVID-19 using a multi-criteria-decision making method

References

• World Health Organization. Coronavirus disease (COVID-19) advice for the public. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-forpublic#:~:text=If%20COVID%2D19%20is%20spreading,a%20bent%20elbow%20or%20tissue
   Google Scholar
• WHO (World Health Organization). WHO guide for standardization of eco- nomic evaluations of immunization programmes (No. WHO/IVB/19.10). Geneva: World Health Organization; 2019
   Google Scholar
• Cavanagh D. Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus. Avian Pathol. 2003 Dec 1;32(6):567–82. doi:10.1080/03079450310001621198.
   PubMed Web of Science ®Google Scholar
• Gao W, Tamin A, Soloff A, D’Aiuto L, Nwanegbo E, Robbins PD, Bellini WJ, Barratt-Boyes S, Gambotto A. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet. 2003 Dec 6;362(9399):1895–96. doi:10.1016/S0140-6736(03)14962-8.
   PubMed Web of Science ®Google Scholar
• Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, AlHajri F, Osterhaus AD, Haagmans BL, Gambotto A. Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014 Oct 14;32(45):5975–82. doi:10.1016/j.vaccine.2014.08.058.
   PubMed Web of Science ®Google Scholar
• Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD Jr, Coccia JA, Graziano RF, Srinivasan M, Lowy I, Finberg RW, et al. Development and characterization of a severe acute respiratory syndrome—associated coronavirus—neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis. 2005 Feb 15;191(4):507–14. doi:10.1086/427242.
   PubMed Web of Science ®Google Scholar
• Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, et al. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods. 2005 Sep 1;128(1–2):21–28. doi:10.1016/j.jviromet.2005.03.021.
   PubMed Web of Science ®Google Scholar
• Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, Vogel L, Hayes N, Sullivan JL, Zaki S, et al. Therapy with a severe acute respiratory syndrome–associated coronavirus–neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian Hamsters. J Infect Dis. 2006 Mar 1;193(5):685–92. doi:10.1086/500143.
   PubMed Web of Science ®Google Scholar
• Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020 Dec;27(1):1–23. doi:10.1186/s12929-020-00695-2.
   PubMed Web of Science ®Google Scholar
• COVID-19 vaccine development pipeline. Vaccine centre, London School of Hygiene and Tropical Medicine. 2021 Mar 1.
   Google Scholar
• Global Polio Eradication Initiative > Data and monitoring > Polio this week. Pakistan launches new polio vaccine, aims for 2016 wipeout. Yahoo News. [accessed 2015 Oct 20]. www.polioeradication.org.
   Google Scholar
• BBC. Polio in Pakistan: drop of 70% recorded this year. BBC. 2015 Jun 3 [accessed 2015 Jun 3]. Aim to Completely Eradicate Polio by Next Year: Pakistan.
   Google Scholar
• Global Polio Eradication Initiative Key countries. [accessed 2019 Dec 23]. https://www.endpolio.com.pk/polioin-Pakistan.
   Google Scholar
• Obregón R, Chitnis K, Morry C, Feek W, Bates J, Galway M, Ogden E. Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan. Bull World Health Organ. 2009;87(8):624–30. doi:10.2471/BLT.08.060863.
   PubMed Web of Science ®Google Scholar
• Jorba J, Diop OM, Iber J, Sutter RW, Wassilak SG, Burns CC. Update on vaccine-derived polioviruses—worldwide, January 2015–May 2016. Morbidity Mortality Weekly Rep. 2016 Aug 5;65(30):76.9503–9.
   Web of Science ®Google Scholar
• Larson H. The CIA’s fake vaccination drive has damaged the battle against polio. The Guardian; 2012.
   Google Scholar
• Imran Ali Teepu. WHO rejects polio imad rumours. Dawn. 2012 Feb 26.
   Google Scholar
• Loyn D. Alarm as Kabul records polio case. BBC News. 2014 Feb 11.
   Google Scholar
• Nebehay S. CORRECTED-Pakistan, Afghanistan must step up fight against polio - WHO. Reuters. 2015 Aug 18.
   Google Scholar
• Explainer: why polio remains endemic in Afghanistan, Pakistan, and Nigeria. Radio Free Europe. 2012 Dec 20.
   Google Scholar
• Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974 Dec;2(4):354–86. doi:10.1177/109019817400200405.
   Google Scholar
• Myers LB, Goodwin R. Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health. 2011 Dec;11(1):1–8. doi:10.1186/1471-2458-11-15.
   PubMed Web of Science ®Google Scholar
• Coe AB, Gatewood SB, Moczygemba LR. The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Inov Pharm. 2012 Jan 1;3(2):1. doi:10.24926/iip.v3i2.257.
   PubMedGoogle Scholar
• Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012 Oct 1;44(2):171–80. doi:10.1007/s12160-012-9366-5.
   PubMed Web of Science ®Google Scholar
• Fisher WA, Kohut T, Salisbury CM, Salvadori MI. Understanding human papillomavirus vaccination intentions: comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men. J Sex Med. 2013 Oct 1;10(10):2455–64. doi:10.1111/jsm.12211.
   PubMed Web of Science ®Google Scholar
• Agarwal V. A/H1N1 vaccine intentions in college students: an application of the theory of planned behavior. J Am Coll Health. 2014 Aug 18;62(6):416–24. doi:10.1080/07448481.2014.917650.
   PubMed Web of Science ®Google Scholar
• Ajzen I. The theory of planned behavior. Organizational Behav Hum Decis Processes. 1991;50(2):179–211. doi:10.1016/0749-5978(91)90020-T.
   Web of Science ®Google Scholar
• Fishbein M, and Ajzen I. Predicting and changing behavior: the reasoned action approach. New York: Psychology press; 2011 Feb 14.
   Google Scholar
• Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: a systematic review. Hum Vaccines Immunother. 2018 Jul 3;14(7):1599–609. doi:10.1080/21645515.2018.1459252. (use in discussion as well).
   PubMed Web of Science ®Google Scholar
• Xiao X, Wong RM. Vaccine hesitancy and perceived behavioral control: a meta-analysis. Vaccine. 2020 Jul 14;38(33):5131–38. doi:10.1016/j.vaccine.2020.04.076. (Use in discussion as well).
   PubMed Web of Science ®Google Scholar
• Chan EY, Cheng CK, Tam GC, Huang Z, Lee PY. Willingness of future A/H7N9 influenza vaccine uptake: a cross-sectional study of Hong Kong community. Vaccine. 2015 Sep 11;33(38):4737–40. doi:10.1016/j.vaccine.2015.07.046.
   PubMed Web of Science ®Google Scholar
• Abbas KM, Kang GJ, Chen D, Werre SR, Marathe A. Demographics, perceptions, and socioeconomic factors affecting influenza vaccination among adults in the United States. PeerJ. 2018 Jul 13;6:e5171. doi:10.7717/peerj.5171.
   PubMed Web of Science ®Google Scholar
• Kwok KO, Li KK, Wei WI, Tang A, Wong SY, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021 Feb 1;114:103854. doi:10.1016/j.ijnurstu.2020.103854.
   PubMed Web of Science ®Google Scholar
• Nguyen KH, Srivastav A, Razzaghi H, Williams W, Lindley MC, Jorgensen C, Abad N, Singleton JA. COVID‐19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination—United States, September and December 2020. doi:10.1111/ajt.16560.
   Google Scholar
• Grochowska M, Ratajczak A, Zdunek G, Adamiec A, Waszkiewicz P, Feleszko W. A comparison of the level of acceptance and hesitancy towards the influenza vaccine and the forthcoming COVID-19 vaccine in the medical community. Vaccines. 2021 May;9(5):475. doi:10.3390/vaccines9050475.
   PubMed Web of Science ®Google Scholar
• Rais A, Viana A. Operations research in healthcare: a survey. Int Trans Oper Res. 2011 Jan;18(1):1–31. doi:10.1111/j.1475-3995.2010.00767.x.
   Web of Science ®Google Scholar
• MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Adunlin G, Diaby V, Xiao H. Application of multicriteria decision analysis in health care: a systematic review and bibliometric analysis. Health Expectations. 2015 Dec;18(6):1894–905. doi:10.1111/hex.12287.
   PubMed Web of Science ®Google Scholar
• Enayati S, Özaltın OY. Optimal influenza vaccine distribution with equity. Eur J Oper Res. 2020 Jun 1;283(2):714–25. doi:10.1016/j.ejor.2019.11.025.
   Web of Science ®Google Scholar
• Silal SP. Operational research: a multidisciplinary approach for the management of infectious disease in a global context. Eur J Oper Res. 2021 Jun 16;291(3):929–34. doi:10.1016/j.ejor.2020.07.037.
   Web of Science ®Google Scholar
• Sarwar A, Imran M. Prioritizing infection prevention and control activities for SARS-CoV-2 (COVID-19): a multi-criteria decision-analysis method. J Healthcare Leadersh. 2021;13:77. doi:10.2147/JHL.S292606.
   PubMed Web of Science ®Google Scholar
• Ivlev I, Vacek J, Kneppo P. Multi-criteria decision analysis for supporting the selection of medical devices under uncertainty. Eur J Oper Res. 2015 Nov 16;247(1):216–28. doi:10.1016/j.ejor.2015.05.075.
   Web of Science ®Google Scholar
• Hezam IM, Nayeem MK, Foul A, Alrasheedi AF. COVID-19 Vaccine: a neutrosophic MCDM approach for determining the priority groups. Results Phys. 2021 Jan 1;20:103654. doi:10.1016/j.rinp.2020.103654.
   PubMed Web of Science ®Google Scholar
• Hair JF, Black WC, Babin BJ, Anderson RE, and Tatham RL. 2006. Multivariate data analysis. Vol. 6. Upper Saddle River: Pearson Prentice Hall.
   Google Scholar
• Hair JF, Anderson RE, Babin BJ, and Black WC. 2010. Multivariate data analysis: a global perspective. Vol. 7. Upper Saddle River: Pearson.
   Google Scholar
• Diaz-Ledezma C, Parvizi J. Surgical approaches for cam femoroacetabular impingement: the use of multicriteria decision analysis. Clin Orthop Relat Res. 2013 Aug;471(8):2509–16. doi:10.1007/s11999-013-2934-6.
   PubMed Web of Science ®Google Scholar
• Diaz-Ledezma C, Lichstein PM, Dolan JG, Parvizi J. Diagnosis of periprosthetic joint infection in medicare patients: multicriteria decision analysis. Clin Orthop Relat Res. 2014 Nov;472(11):3275–84. doi:10.1007/s11999-014-3492-2.
   PubMed Web of Science ®Google Scholar
• Munoz DA, Nembhard HB, Kraschnewski JL. Quantifying complexity in translational research: an integrated approach. Int J Health Care Qual Assur. 2014 Oct 7;27(8):760–76. doi:10.1108/IJHCQA-01-2014-0002.
   PubMedGoogle Scholar
• Saaty TL. A scaling method for priorities in hierarchical structures. J Math Psychol. 1977 Jun 1;15(3):234–81. doi:10.1016/0022-2496(77)90033-5.
   Web of Science ®Google Scholar
• Saaty TL. Highlights and critical points in the theory and application of the analytic hierarchy process. Eur J Oper Res. 1994 May 5;74(3):426–47. doi:10.1016/0377-2217(94)90222-4.
   Web of Science ®Google Scholar
• Karayalcin II. The analytic hierarchy process: planning, priority setting, resource allocation: Thomas L. £ 15.65. New York (NY): SAATY McGraw-Hill; 1980. p. xiii+ 287.
   Google Scholar
• Saaty TL, and Vargas LG. Prediction, projection and forecasting: applications of the analytic hierarchy process in economics, finance, politics, games and sports. Springer Netherlands Copyright Holder - Springer Science+Business Media New York: Springer; 1991.
   Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014 Apr 17;32(19):2150–59. doi:10.1016/j.vaccine.2014.01.081.
   PubMed Web of Science ®Google Scholar
• Habersaat KB, Jackson C. Understanding vaccine acceptance and demand—and ways to increase them. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2020 Jan;63(1):32–39. doi:10.1007/s00103-019-03063-0.
   PubMed Web of Science ®Google Scholar
• Cooper S, Schmidt BM, Sambala EZ, Swartz A, Colvin CJ, Leon N, Betsch C, Wiysonge CS. Factors that influence parents’ and informal caregivers’ acceptance of routine childhood vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019 Feb;2019(2). doi:10.1002/14651858.CD013265.
   PubMedGoogle Scholar
• Thunstrom L, Ashworth M, Finnoff D, Newbold S Hesitancy towards a COVID-19 vaccine and prospects for herd immunity. Available at SSRN 3593098. 2020 Jun 30. Thunstrom, Linda and Ashworth, Madison and Finnoff, David and Newbold, Stephen, Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity (June 30, 2020). doi:10.2139/ssrn.3593098.
   Google Scholar
• Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, Rubin GJ, Sevdalis N. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccines Immunother. 2021 Jun 3;17(6):1612–21. doi:10.1080/21645515.2020.1846397.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Hoq M, Measey MA, Danchin M. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021 May 1;21(5):e110. doi:10.1016/S1473-3099(20)30724-6.
   PubMed Web of Science ®Google Scholar
• Williams L, Gallant AJ, Rasmussen S, Brown Nicholls LA, Cogan N, Deakin K, Young D, Flowers P. Towards intervention development to increase the uptake of COVID‐19 vaccination among those at high risk: outlining evidence‐based and theoretically informed future intervention content. Br J Health Psychol. 2020 Nov;25(4):1039–54. doi:10.1111/bjhp.12468.
   PubMed Web of Science ®Google Scholar
• Faasse K, Newby J. Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions. Front Psychol. 2020;11. doi:10.3389/fpsyg.2020.551004.
   Web of Science ®Google Scholar
• Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, van Exel J, Schreyögg J, Stargardt T Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. doi.10.1007/s10198-020-01208-6
   Google Scholar
• Jamison AM, Quinn SC, Freimuth VS. You don’t trust a government vaccine”: narratives of institutional trust and influenza vaccination among African American and white adults. Soc Sci Med. 2019 Jan 1;221:87–94. doi:10.1016/j.socscimed.2018.12.020.
   PubMed Web of Science ®Google Scholar